Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: Immunohorizons. 2019 Apr 1;3(4):133–148. doi: 10.4049/immunohorizons.1900022

FIGURE 2. Experimental design for serological analyses.

FIGURE 2

BALB/c mice were experimentally primed with QIV on day 0, followed by IIV8 on day 28 and IIV5 on day 56 or IIV5 on day 28 and IIV8 on day 56. IIV Ags were adjuvanted with AS01 or AS03 or administered nonadjuvanted. Control groups consisted of two injections of QIV (standard of care) or three injections of PBS. Blood samples were collected on days 0, 28, 56, and 84.